Juan Besalduch

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

Anna Sureda, M. Constans, A Iriondo et al. · Annals of Oncology · 2005 · 220 citations · Full text

Medicine, Hematology, Oncology +17

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Anna Sureda, Carmen Canals, R. Arranz et al. · Haematologica · 2011 · 213 citations · Full text

Medicine, Immunology, Oncology +17

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

Juan José Lahuerta, Joaquín Martínez‐López, Javier de la Serna et al. · British Journal of Haematology · 2000 · 107 citations · Full text

Medicine, Hematology, Oncology +14

Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade)a/Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcadea as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.

Laura Rosiñol, M. Teresa Cibeira, Joaquín Martínez‐López et al. · Blood · 2009 · 45 citations

Medicine, Hematology, Oncology +17

In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy

Josep Muncunill, Pere Vaquer, A. Galmés et al. · Journal of Clinical Apheresis · 2002 · 34 citations

Medicine, Hematology, Hematopathology +14